LIFE SCIENCES, LIFE SCIENCES, VIDEO

Manufacturing Autologus Ex Vivo Genetically Modified Cell Therapies have Challenges, but the Future is Bright

Review the supply chain Examine the contributors of costs Solution for industrial scale viral vector manufacturing Cell processing and viral transduction hubs Rapid analytics for product testing Brighter future for patients with fitter cell therapies — Joseph Tarnowski SVP, Cell & Gene Therapy, R&D Medicinal Science and Technology GSK Prior to his current role in CGT, Joe was the Senior Vice President of Biopharm CMC R&D. Before joining GSK in June, 2010, Joe was the Senior Vice President, Biologics Manufacturing and Process Development in the Technical Operations division of Bristol-Myers Squibb Co. in New Brunswick, NJ. Joe was responsible for…

Continue reading